Nike Axes Headcount To Save Cost, Cuts Over 1,600 Jobs: Report
Nike reportedly plans to cut 2% of its workforce to save costs and focus on key categories. The reduction won't impact employees in stores or innovation team.
NY Pension Fund Prioritizes Climate Over Big Oil Profits: Restricts Investments In 8 Companies, Including ExxonMobil
NY State pension fund restricts investments in 8 oil and gas companies, including Exxon, due to climate risk.
EXCLUSIVE: Value Investor Is ‘Very Happy To Take Advantage’ Of Top Gold Miner At Historical Discount
Gold stocks at 50-80% discount present a unique opportunity. Newmont is undervalued despite 10% rise in gold prices.
Why Is Women Health-Focused Organon Stock Trading Higher On Thursday?
Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, driven by Follistim AQ's 63% growth. Biosimilar revenue surges by 49%.
Why Is Alnylam Pharmaceuticals Stock Trading Lower On Thursday?
Alnylam Pharmaceuticals' updates on HELIOS-B Phase 3 study and FDA clearance for ALN-APP Phase 1 study. Fiscal year 2024 guidance of $1.4 billion–$1.5 billion in combined net product revenues.
Banks With High Commercial Real Estate Loan Exposure In Regulatory Spotlight: Valley National Bancorp And 15 Others To Watch
US banks with large CRE loan portfolios face increased regulatory scrutiny, but NYCB stands out with steady growth despite exceeding threshold.
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What’s Driving Markets Thursday?
US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small caps outperform. Tesla, Wells Fargo, and CBRE rally on positive news while Deer & Antero Resources shares drop. Other companies react to earnings.
Why Air Products & Chemicals Shares Are Rising Today
BofA Securities upgrades Air Products & Chemicals to Buy with a price target of $264. Analyst cites valuation disconnect, lower risk in projects, and strong base business.
West Pharmaceutical’s 2024 Outlook Cautious, Analysts Remain Optimistic
West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth, emphasizing inventory management strategies.
What’s Going On With Cisco Systems Shares Today?
Cisco Inc (CSCO) shares drop after issuing lower Q3 & FY24 guidance, announcing workforce reduction.